Wed.Apr 23, 2025

article thumbnail

Improving Patient Trust with Digital Communication

MedCity News

Patients need tailored touchpoints throughout their health journey to stay engaged with their care plan. To do this effectively, healthcare organizations must leverage technology and digital communication strategies to drive and retain patient engagement and experience end-to-end. The post Improving Patient Trust with Digital Communication appeared first on MedCity News.

Patients 165
article thumbnail

The Bold New Healthcare and Medical Sales Era

Evolve Your Success

Breaking Barriers: Navigating the Evolving World of Healthcare and Medical Sales. Join Jasper Freeman, Director of National Accounts at SC Pharmaceuticals, as he shares his transformative journey in medical sales. From pioneering the heart failure treatment device, Ferosix, to making groundbreaking strides in home healthcare, Jasper unveils how cutting-edge technology is reducing hospital visits and revolutionizing patient care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bristol Myers Squibb Schizophrenia Drug Fails Pivotal Test as an Add-On to Antipsychotics

MedCity News

Bristol Myers Squibbs Cobenfy failed to outdistance a placebo in a Phase 3 test that evaluated the drug as an adjunct to antipsychotics in schizophrenia patients. Last September, the FDA approved Cobenfy as a standalone schizophrenia treatment. The post Bristol Myers Squibb Schizophrenia Drug Fails Pivotal Test as an Add-On to Antipsychotics appeared first on MedCity News.

FDA 147
article thumbnail

Customer Engagement Strategies for Pharma Marketing

Pharma Marketing Network

Introduction In 2025, the pharmaceutical industry finds itself in the midst of a digital transformation, where trust and personalization are more important than ever. Pharma brands are no longer competing solely on productstheyre competing on relationships. As a result, customer engagement strategies have taken center stage in shaping how companies connect with healthcare professionals (HCPs), patients, caregivers, and stakeholders.

article thumbnail

State of AI in Sales & Marketing 2025

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

article thumbnail

How Leveraging Information for Action can Build a More Sustainable Healthcare System

MedCity News

By aligning incentives and encouraging collaboration across sectors, we can build a resilient system that adapts to changing needs and delivers value to all stakeholders. The post How Leveraging Information for Action can Build a More Sustainable Healthcare System appeared first on MedCity News.

More Trending

article thumbnail

World Class Health Secures $10M for Global Centers of Excellence Network

MedCity News

World Class Health’s $10 million raise was led by Transformation Capital. It comes six months after the company secured $8 million in seed funding. The post World Class Health Secures $10M for Global Centers of Excellence Network appeared first on MedCity News.

article thumbnail

Boehringer to expand oncology presence with $572m Tessellate Bio deal

Pharmaceutical Technology

The agreement gives Boehringer access to Tessellates novel approach targeting ALT-dependent tumours.

97
article thumbnail

The 4 Best Places to Buy Affordable Spectrometers for Lab Use

MedCity News

[Sponsored] Equip your laboratory with cost-effective instruments. Explore the top four companies for affordable spectrometers. The post The 4 Best Places to Buy Affordable Spectrometers for Lab Use appeared first on MedCity News.

130
130
article thumbnail

Eli Lilly sues Mochi Health and others for ‘deceptive’ tirzepatide marketing

Pharmaceutical Technology

The lawsuit filings are the latest turn in a long-running legal saga between GLP-1RAs makers and compounders.

article thumbnail

The Intersection of AI and Sales: Personalization Without Compromise

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

article thumbnail

Axtria unveils transformational agentic AI platform for life sciences

pharmaphorum

Axtria Inc., an AI-first data analytics innovator and global provider of cloud software to the life sciences industry, today announced its next generation of Axtria InsightsMAx, powered by agentic AI.

90
article thumbnail

UCL researchers launch congenital muscular dystrophy research programme

PharmaTimes

The university has been awarded a 1m grant from LifeArc and Muscular Dystrophy UK

66
article thumbnail

Roche gets EU okay for chest pain algorithm

pharmaphorum

Roche has claimed a CE Mark in the EU for an AI algorithm that can help doctors decide whether patients with chest pain are having a heart attack.

Doctors 84
article thumbnail

PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project

PharmaTech

The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research communitys understanding of Alzheimers disease and other dementias in diverse populations.

59
article thumbnail

The GTM Intelligence Era: ZoomInfo 2025 Customer Impact Report

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

article thumbnail

Senior FDA resignations gut drug advertising function

pharmaphorum

Two senior officials at the FDA's drug promotion office have resigned, leading to speculation that a clampdown on some advertising may be on the way.

FDA 82
article thumbnail

LogiPharma Europe 2025: Three Ways to Turn Sustainability Pledges Into Progress

Pharmaceutical Commerce

Joydeep Ganguly, SVP, corporate operations, interim CIO, Gilead Sciences, shares how stakeholders can drive meaningful, lasting impact by turning pledges into proof points, exercising patience, and embedding sustainability into core business operations.

59
article thumbnail

Swiss biotech Veraxa vaults to Nasdaq listing with SPAC deal

pharmaphorum

Cancer drug developer Veraxa Biotech has reached a deal to merge with a SPAC in a deal that will give it a Nasdaq listing and a $1.

76
article thumbnail

ConcertAI and Bayer to boost precision oncology with AI and ML insights

Pharmaceutical Technology

ConcertAI has announced an agreement with Bayer that allows the latter to utilise its Translational360 and AI SaaS solutions.

59
article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

First drug for rare disease APDS cleared for NHS use

pharmaphorum

Pharming's Joenja has become the first disease-modifying drug that can be used by the NHS to treat APDS, an ultra-rare immunodeficiency disorder

59
article thumbnail

TNF and Renova Health use AI to identify patients for GLP-1 treatments

Pharmaceutical Technology

TNF and Renova Health are set to use AI and ML for the identification of high-risk subjects who could benefit from GLP-1 therapies

article thumbnail

Has trial result burst BMS' Cobenfy bubble?

pharmaphorum

Sky-high sales prospects for Bristol Myers Squibb's new schizophrenia treatment Cobenfy may have to be scaled down after a failed clinical trial

article thumbnail

Full COVID-19 mRNA Vaccination Course Induces Long-Term Antibody, Memory B-Cell Response

Pharmacy Times

New research highlights the long-lasting effectiveness of mRNA COVID-19 vaccines, showing sustained B-cell and antibody responses in health care workers over 3 years.

53
article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

Making Real-World Evidence Work for Medicare: What CMS’ Draft Guidance Gets Right and What Needs Work

PharmExec

CMS draft guidance on real-world data study protocols marks a significant move toward transparency and rigor in Medicare coverage decisions.

52
article thumbnail

EditCo Bio secures access to Promega’s technologies in licensing deal

Pharmaceutical Technology

EditCo Bio has entered a licensing agreement to secure access to Promegas protein-tagging and bioluminescent identification technologies.

52
article thumbnail

Sebela’s Novel Potassium-Competitive Acid Blocker Demonstrates Promise in Gastroesophageal Reflux Disease

PharmExec

Results from the dual Phase III TRIUMpH trials demonstrated the statistical superiority of tegoprazan over lansoprazole in patients with erosive esophagitis and non-erosive reflux disease.

article thumbnail

USA Today Names CCC a Top Workplace for the Fourth Year in a Row

Copyright Clearance Center

National Recognition for CCCs People-First Workplace Culture DANVERS, Mass.

52
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Akeso’s PD-1/VEGF Bispecific Antibody Demonstrates Meaningful Progression-Free Survival Benefits in Advanced Squamous NSCLC

PharmExec

In the Phase III HARMONi-6 trial, ivonescimab plus chemotherapy significantly outperformed tislelizumab plus chemotherapy as a first-line treatment for advanced squamous non-small cell lung cancer.

52
article thumbnail

Synthetic hormones and the future of contraception

Pharmaceutical Technology

Contraception for women has seen little change over the past 50 years, with the most prevalent contraceptive pills containing synthetic hormones.

52
article thumbnail

Bristol Myers Squibb’s Cobenfy Falls Short in Phase III Trial as Add On Therapy for Schizophrenia

PharmExec

In the Phase III ARISE trial, Cobenfy administered as an adjunctive treatment to atypical antipsychotics for patients with inadequately controlled schizophrenia did not achieve statistically significant improvements.